Diagnosis of Primary Trimethylaminuria in an Affected Patient With a Rare Genotype in Sub‐Saharan Africa
Authors:
Open Access
- 12 March 2025
- journal article
- Published by Wiley in JIMD Reports
- Vol. 66 (2) , e70005
Abstract
Primary trimethylaminuria (TMAU) is characterized by systemic accumulation of trimethylamine (TMA) due to the deficient activity of flavin‐containing monooxygenase 3 (FMO3). The disorder does not have detrimental pathophysiological consequences, but patients develop psychological symptoms due to the emotionally debilitating bodily odor defined as decaying fish that affects their quality of life. Here, we illustrate the utility of a diagnostic workup on an adolescent with primary TMAU, including biochemical and genetic investigations that confirm the diagnosis. A direct substrate (TMA) loading protocol was used, followed by the collection of urine samples at predetermined intervals. The conversion of TMA to trimethylamine oxide (TMAO), monitored by 1H‐NMR spectrometry, showed a compromised FMO3 metabolic capacity at baseline, becoming more pronounced after loading commenced. The eight coding exons of the FMO3 gene were Sanger sequenced, revealing a homozygous missense variant, c.23T>C (p.Ile8Thr), as well as two known homozygous variants, c.472G>A (p.Glu158Lys) and c.923A>G (pGlu308Gly), associated with no to mild presentation of TMAU. The advantage of direct substrate‐to‐product monitoring is the elimination of alternative contributors to the odor that would result in the diagnosis of secondary TMAU. The combined functional and genetic approach provided adequate evidence to describe the first primary TMAU patient reported in sub‐Saharan Africa with a genotype not yet described in a homozygous state. Our findings motivate a comprehensive biochemical and genetic approach to discriminate between primary and secondary TMAU. Subsequently, this targeted approach can provide advice on therapeutic management for optimal emotional well‐being.Keywords
This publication has 26 references indexed in Scilit:
- Trimethylaminuria and a humanFMO3 mutation databaseHuman Mutation, 2003
- SIFT: predicting amino acid changes that affect protein functionNucleic Acids Research, 2003
- A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopyPharmacogenetics, 2000
- Mild trimethylaminuria caused by common variants in FM03 geneThe Lancet, 1999
- Trimethylaminuria Is Caused by Mutations of the FMO3 Gene in a North American CohortMolecular Genetics and Metabolism, 1999
- Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxicationHuman Molecular Genetics, 1998
- Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndromeNature Genetics, 1997
- The fish odour syndrome: biochemical, familial, and clinical aspects.BMJ, 1993
- Trimethylaminuria: The detection of carriers using a trimethylamine load testJournal of Inherited Metabolic Disease, 1988
- TRIMETHYLAMINURIA: THE FISH-ODOUR SYNDROMEThe Lancet, 1970